Healthcare
Investing News
Market News
Johnson & Johnson to Buy Momenta Pharmaceutical for $6.5 Billion
Johnson & Johnson (NYSE: JNJ) announced Wednesday it would be purchasing Momenta Pharmaceuticals for USD6.5 Billion in cash as it strives to grow its portfolio of drugs for autoimmune...